283 related articles for article (PubMed ID: 27463221)
1. Ocular Penetration and Pharmacokinetics of Ripasudil Following Topical Administration to Rabbits.
Isobe T; Kasai T; Kawai H
J Ocul Pharmacol Ther; 2016 Sep; 32(7):405-14. PubMed ID: 27463221
[TBL] [Abstract][Full Text] [Related]
2. Effects of ripasudil hydrochloride hydrate (K-115), a Rho-kinase inhibitor, on ocular blood flow and ciliary artery smooth muscle contraction in rabbits.
Ohta Y; Takaseki S; Yoshitomi T
Jpn J Ophthalmol; 2017 Sep; 61(5):423-432. PubMed ID: 28653193
[TBL] [Abstract][Full Text] [Related]
3. Effects of K-115, a rho-kinase inhibitor, on aqueous humor dynamics in rabbits.
Isobe T; Mizuno K; Kaneko Y; Ohta M; Koide T; Tanabe S
Curr Eye Res; 2014 Aug; 39(8):813-22. PubMed ID: 24502505
[TBL] [Abstract][Full Text] [Related]
4. Prolonged exposure to loteprednol etabonate in human tear fluid and rabbit ocular tissues following topical ocular administration of Lotemax gel, 0.5%.
Glogowski S; Lowe E; Siou-Mermet R; Ong T; Richardson M
J Ocul Pharmacol Ther; 2014 Feb; 30(1):66-73. PubMed ID: 24325539
[TBL] [Abstract][Full Text] [Related]
5. Ocular pharmacokinetics of besifloxacin following topical administration to rabbits, monkeys, and humans.
Proksch JW; Granvil CP; Siou-Mermet R; Comstock TL; Paterno MR; Ward KW
J Ocul Pharmacol Ther; 2009 Aug; 25(4):335-44. PubMed ID: 19492955
[TBL] [Abstract][Full Text] [Related]
6. Characterization of ocular pharmacokinetics of tilisolol after instillation into anesthetized rabbits.
Sasaki H; Yamamura K; Mukai T; Nishida K; Nakamura J; Nakashima M; Ichikawa M
Biol Pharm Bull; 1999 Nov; 22(11):1253-5. PubMed ID: 10598041
[TBL] [Abstract][Full Text] [Related]
7. The Anti-Inflammatory Effect of Ripasudil (K-115), a Rho Kinase (ROCK) Inhibitor, on Endotoxin-Induced Uveitis in Rats.
Uchida T; Honjo M; Yamagishi R; Aihara M
Invest Ophthalmol Vis Sci; 2017 Oct; 58(12):5584-5593. PubMed ID: 29084331
[TBL] [Abstract][Full Text] [Related]
8. Characterization of ocular pharmacokinetics of beta-blockers using a diffusion model after instillation.
Yamamura K; Sasaki H; Nakashima M; Ichikawa M; Mukai T; Nishida K; Nakamura J
Pharm Res; 1999 Oct; 16(10):1596-601. PubMed ID: 10554103
[TBL] [Abstract][Full Text] [Related]
9. Ocular pharmacokinetics/pharmacodynamics of besifloxacin, moxifloxacin, and gatifloxacin following topical administration to pigmented rabbits.
Proksch JW; Ward KW
J Ocul Pharmacol Ther; 2010 Oct; 26(5):449-58. PubMed ID: 20874668
[TBL] [Abstract][Full Text] [Related]
10. Increase in the OCT angiographic peripapillary vessel density by ROCK inhibitor ripasudil instillation: a comparison with brimonidine.
Chihara E; Dimitrova G; Chihara T
Graefes Arch Clin Exp Ophthalmol; 2018 Jul; 256(7):1257-1264. PubMed ID: 29520478
[TBL] [Abstract][Full Text] [Related]
11. Rho-Associated Kinase Inhibitor Eye Drop (Ripasudil) Transiently Alters the Morphology of Corneal Endothelial Cells.
Okumura N; Okazaki Y; Inoue R; Nakano S; Fullwood NJ; Kinoshita S; Koizumi N
Invest Ophthalmol Vis Sci; 2015 Nov; 56(12):7560-7. PubMed ID: 26618648
[TBL] [Abstract][Full Text] [Related]
12. Effect of the Rho-Associated Kinase Inhibitor Eye Drop (Ripasudil) on Corneal Endothelial Wound Healing.
Okumura N; Okazaki Y; Inoue R; Kakutani K; Nakano S; Kinoshita S; Koizumi N
Invest Ophthalmol Vis Sci; 2016 Mar; 57(3):1284-92. PubMed ID: 26998714
[TBL] [Abstract][Full Text] [Related]
13. Vascular Normalization by ROCK Inhibitor: Therapeutic Potential of Ripasudil (K-115) Eye Drop in Retinal Angiogenesis and Hypoxia.
Yamaguchi M; Nakao S; Arita R; Kaizu Y; Arima M; Zhou Y; Kita T; Yoshida S; Kimura K; Isobe T; Kaneko Y; Sonoda KH; Ishibashi T
Invest Ophthalmol Vis Sci; 2016 Apr; 57(4):2264-76. PubMed ID: 27124322
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the Ocular Penetration and Pharmacokinetics Between Natamycin and Voriconazole After Topical Instillation in Rabbits.
Zhao X; Tong Y; Wang X; Zhang X; Chen S; Lu H
J Ocul Pharmacol Ther; 2018; 34(6):460-467. PubMed ID: 29792548
[TBL] [Abstract][Full Text] [Related]
15. The Relationship of Brimonidine Concentration in Vitreous Body to the Free Concentration in Retina/Choroid Following Topical Administration in Pigmented Rabbits.
Shinno K; Kurokawa K; Kozai S; Kawamura A; Inada K; Tokushige H
Curr Eye Res; 2017 May; 42(5):748-753. PubMed ID: 27854122
[TBL] [Abstract][Full Text] [Related]
16. Ocular pharmacokinetics of dorzolamide and brinzolamide after single and multiple topical dosing: implications for effects on ocular blood flow.
Kadam RS; Jadhav G; Ogidigben M; Kompella UB
Drug Metab Dispos; 2011 Sep; 39(9):1529-37. PubMed ID: 21673129
[TBL] [Abstract][Full Text] [Related]
17. Iganidipine, a new water-soluble Ca2+ antagonist: ocular and periocular penetration after instillation.
Ishii K; Matsuo H; Fukaya Y; Tanaka S; Sakaki H; Waki M; Araie M
Invest Ophthalmol Vis Sci; 2003 Mar; 44(3):1169-77. PubMed ID: 12601046
[TBL] [Abstract][Full Text] [Related]
18. Additive Intraocular Pressure-Lowering Effects of Ripasudil with Glaucoma Therapeutic Agents in Rabbits and Monkeys.
Kaneko Y; Ohta M; Isobe T; Nakamura Y; Mizuno K
J Ophthalmol; 2017; 2017():7079645. PubMed ID: 28540083
[TBL] [Abstract][Full Text] [Related]
19. Ocular absorption behavior of palmitoyl tilisolol, an amphiphilic prodrug of tilisolol, for ocular drug delivery.
Kawakami S; Nishida K; Mukai T; Yamamura K; Kobayashi K; Sakaeda T; Nakamura J; Nakashima M; Sasaki H
J Pharm Sci; 2001 Dec; 90(12):2113-20. PubMed ID: 11745770
[TBL] [Abstract][Full Text] [Related]
20. Ocular distribution of difluprednate ophthalmic emulsion 0.05% in rabbits.
Tajika T; Isowaki A; Sakaki H
J Ocul Pharmacol Ther; 2011 Feb; 27(1):43-9. PubMed ID: 21118027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]